Routine Neutral

2026-06-25 11:39

- Trading window for Global Health Limited shares to close from July 01, 2026. - It will reopen 48 hours after Q1 FY27 financial results declaration (for quarter ended June 30, 2026) for insider trading prevention.

Ownership Neutral

2026-06-24 15:57

- The company allotted 4,000 Equity Shares of face value Rs. 2/- each at a premium of Rs. 1,287 per share to GHL Employees Welfare Trust under the GHL-Employee Long Term Share Based Incentive Plan 2024. These shares were allotted on June 24, 2026. - Post allotment, the paid-up share capital increased to Rs. 53,77,43,564/- (26,88,71,782 Equity Shares).

Business Update Neutral

2026-06-23 15:52

- Investor Meeting Schedule - June 26, 2026: One-to-one virtual meeting with IKIGAI Asset Manager Holdings Private Limited. - June 30, 2026: One-to-one virtual meeting with Enam Asset Management Company Private Limited.

Business Update Neutral

2026-06-23 15:52

- Investor Meeting Schedule - Meeting with IKIGAI Asset Manager Holdings Private Limited on June 26, 2026 (one to one, Virtual) - Meeting with Enam Asset Management Company Private Limited on June 30, 2026 (one to one, Virtual)

Business Update Neutral

2026-06-18 15:24

- Investor Meeting Schedule - Date/Location: June 24, 2026 (Noida), June 25, 2026 (Gurugram), June 26, 2026 (Lucknow) - Type: One-to-one, In Person meetings organized by Nuvama Institutional Equities. - No Unpublished Price Sensitive Information will be shared.

Business Update Neutral

2026-06-18 15:24

- Concall/Investor Meeting Schedule - Meetings with Analysts/Institutional Investors organized by Nuvama Institutional Equities. - Scheduled Dates & Locations: - June 24, 2026: Noida (one to one, In Person) - June 25, 2026: Gurugram (one to one, In Person) - June 26, 2026: Lucknow (one to one, In Person)

Business Update Neutral

2026-06-18 15:24

- Intimation for Schedule of Analysts/Institutional Investor Meetings - Company Management will meet Investors/Analysts in meetings organised by Nuvama Institutional Equities. - June 24, 2026: One-to-one meeting in Noida (In Person). - June 25, 2026: One-to-one meeting in Gurugram (In Person). - June 26, 2026: One-to-one meeting in Lucknow (In Person). - No Unpublished Price Sensitive Information will be shared.

Business Update Neutral

2026-06-17 15:47

- Investor/Analyst Meetings Scheduled - Date: June 22, 2026 (Group meeting in Lucknow, In Person) - Date: June 23, 2026 (Group meeting in Noida, In Person) - Meetings organized by Elara Securities. - No Unpublished Price Sensitive Information (UPSI) will be shared.

Business Update Neutral

2026-06-17 15:46

- Investor/Analyst Meetings Schedule - Meeting Date 1: June 22, 2026 (Lucknow, In Person) - Meeting Date 2: June 23, 2026 (Noida, In Person) - Meetings organized by Elara Securities. - No Unpublished Price Sensitive Information (UPSI) will be shared.

Business Update Neutral

2026-06-16 16:19

- Concall Schedule - Concall Date: June 19, 2026 - Meeting Type: Group Meeting - Meeting Mode: In Person - Meeting Place: Noida

Business Update Neutral

2026-06-13 17:05

- Analyst/Institutional Investor Meetings Scheduled - June 17, 2026: Group Meeting with JP Morgan in Noida (In Person). - June 18, 2026: One-to-One Meeting with IIFL Capital in London (In Person).

Business Update Neutral

2026-06-13 17:05

- Intimation for Schedule of Analysts/Institutional Investors Meetings by Global Health Limited. - Meeting with JP Morgan: Group Meeting on June 17, 2026, in Noida (In Person). - Meeting with IIFL Capital: One to One Meeting on June 18, 2026, in London (In Person). - No Unpublished Price Sensitive Information (UPSI) will be shared.

Business Update Positive

2026-06-12 13:26

- Global Health Limited (Medanta) received a Letter of Intent (LOI) dated June 11, 2026. - The LOI is from the Government of Haryana for establishing a Medical College with 150 MBBS seats at Medanta – The Medicity, Gurugram.

Business Update Neutral

2026-06-10 18:09

- Investor Meeting Schedule - Meeting Date: June 15, 2026 - Meeting Type: One to One (In Person) - Place: Gurugram

Business Update Neutral

2026-06-08 18:15

- Investor/Analyst Meeting Scheduled - Meeting Date: June 11, 2026 - Meeting Type: One to One, In Person - Organized by Emkay Investment Managers Limited

Routine Neutral

2026-06-04 18:19

New Filing detected. See link for details.

Business Update Neutral

2026-06-04 18:18

- Concall Schedule - Concall Date: June 09, 2026 and June 10, 2026 - Concall Details: Global Health Limited (MEDANTA) management will meet Institutional Investors in One to One & Group Meetings organized by Kotak Institutional Equity India Corporate Day - Singapore 2026, in Singapore.

Business Update Neutral

2026-06-01 14:56

Global Health Limited (MEDANTA) announced an intimation for an Analysts/Institutional Investors Meeting. The company's management will meet with Prudent Corporate Advisory Ltd on June 04, 2026, in a virtual one-to-one format. The filing explicitly states that no Unpublished Price Sensitive Information is proposed to be shared during the meeting.

Governance Positive

2026-05-23 16:00

Global Health Limited's Nomination & Remuneration Committee on May 23, 2026, approved the allotment of 15,900 Equity Shares of face value Rs. 2/- each at a premium of Rs. 1,239 per share to the GHL Employees Welfare Trust under the GHL LTIP 2024 Plan. This action increases the company's paid-up share capital from Rs. 53,77,03,764/- to Rs. 53,77,35,564/-. The shares will be transferred to eligible employees' Demat Accounts.

Business Update Neutral

2026-05-22 18:03

Global Health Limited (MEDANTA) announced it will meet with institutional investors/analysts. Management will hold one-on-one meetings with ICICI Prudential AMC Ltd on May 27, 2026, in Gurugram, and IIFL Capital Asset Management Limited on May 28, 2026, virtually. No Unpublished Price Sensitive Information will be shared during these meetings.

Business Update Neutral

2026-05-22 18:03

Global Health Limited (MEDANTA) has scheduled one-on-one meetings with institutional investors. The company's management will meet ICICI Prudential AMC Ltd on May 27, 2026, in Gurugram, and IIFL Capital Asset Management Limited on May 28, 2026, virtually. The company explicitly stated that no Unpublished Price Sensitive Information (UPSI) will be shared during these interactions.

Business Update Positive

2026-05-20 10:15

The management discussed a strong FY26 performance and positive outlook. The Noida hospital is expected to break even in H2 FY27. The company plans to add approximately 500 beds in existing hospitals in the short term and about 2,700 beds through 5 greenfield projects over the next 3-4 years. Total project capex for the next 5 years is estimated at INR 45,000 Cr, with FY27 capex projected at INR 800-900 Cr and FY28 at INR 600-700 Cr. Growth will be driven by adding new services, procedures, specialties, expanding existing facilities, and new units like the 80-bed Indore hospital (Q2 FY27). Mature unit margins are expected to remain stable at 24-25%. The company maintains a strong net cash position of INR 5,906 Cr as of March 31, 2026.

Business Update Neutral

2026-05-15 16:14

Global Health Limited (Medanta) announced the availability of the audio recording of its Earnings Conference Call held on May 15, 2026. The call discussed the financial results for the Fourth Quarter and Financial Year ended March 31, 2026. The recording can be accessed through the link provided on the company's investor relations website.

Financials Positive

2026-05-14 18:45

Consolidated Revenue from operations for Q4 FY26 was INR 1,159 Cr vs INR 931.3 Cr (▲24.5% YoY), EBITDA was INR 290.6 Cr vs INR 247.8 Cr (▲17.3% YoY), and PAT was INR 141.7 Cr vs INR 101.4 Cr (▲39.7% YoY). EBITDA Margin was 24.3% vs 26.0% (▼170bps). The company reported its highest ever quarterly total income and strong operational performance, including an increase in bed capacity and patient volumes.

Governance Negative

2026-05-14 17:00

CRITICAL RED FLAG DETECTED

The Board of Directors of Global Health Limited met on May 14, 2026, approving the Audited Standalone and Consolidated Financial Results for Q4 and the financial year ended March 31, 2026. A final dividend of Rs. 0.50/- per equity share was recommended. The Board also approved the appointment of Mr. Kedar Ashok Apte as Chief Marketing & Growth Officer and Mr. Jagdeep Singh as General Counsel (both Senior Management Personnel). Ms. Richa Singh, an existing Senior Management Personnel, resigned, effective May 20, 2026.

Governance Negative

2026-05-14 17:00

CRITICAL RED FLAG DETECTED

Global Health Limited's Board of Directors approved the Audited Standalone and Consolidated Financial Results for Q4 and FY ended March 31, 2026. A final dividend of Rs. 0.50/- per equity share (25% on Rs. 2/- face value) was recommended for FY26. The board also appointed Mr. Kedar Ashok Apte as Chief Marketing & Growth Officer and Mr. Jagdeep Singh as General Counsel. Ms. Richa Singh, a Senior Management Personnel, resigned effective May 20, 2026.

Routine Neutral

2026-05-14 16:59

New Filing detected. See link for details.

Financials Neutral

2026-05-11 18:21

Global Health Limited (Medanta) announced an earnings conference call for its Q4 FY2026 financial results. The call is scheduled for Friday, May 15, 2026, at 2:00 PM IST, hosted by ICICI Securities. Key management, including the Chairman & MD, Group CEO, and CFO, will represent the company.

Business Update Positive

2026-05-11 11:42

Global Health Limited's Nomination & Remuneration Committee approved the grant of 10,000 Employee Stock Options (ESOPs) to one employee under the GHL LTIP 2024 Plan on May 11, 2026. The exercise price per option is ₹960. These options will vest over a maximum of 5 years and can be exercised within 3 years from the vesting of the last installment.

MEDANTA

Global Health Limited

Price Chart

Filing History

Unlock Full History